Cardiolyse
Founded Year
2015Stage
Biz Plan Competition | AliveMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+10 points in the past 30 days
About Cardiolyse
Cardiolyse is an e-healthcare company. It focuses on analytics of the human heart and electro signals providing cardio care. Cardiolyse addresses early cardiovascular disease detection or prevention through a post-discharge and chronic cardiovascular disease (CVD) patient monitoring platform. The company was founded in 2015 and is based in Helsinki, Finland.
Missing: Cardiolyse's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Cardiolyse's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Cardiolyse Patents
Cardiolyse has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/30/2015 | 12/24/2019 | Cardiac arrhythmia, Cardiac electrophysiology, Heart diseases, Cardiology, Cardiovascular physiology | Grant |
Application Date | 9/30/2015 |
|---|---|
Grant Date | 12/24/2019 |
Title | |
Related Topics | Cardiac arrhythmia, Cardiac electrophysiology, Heart diseases, Cardiology, Cardiovascular physiology |
Status | Grant |
Latest Cardiolyse News
Jun 10, 2022
Cardiolyse enables remote vital sign monitoring and personalized patient reports for early diagnostics of cardiovascular disease (CVD) patients – basically it can predict a stroke two months before it occurs. – Cardiolyse adds value to primary as well as secondary prevention, giving early signs to healthcare professionals and engaging patient self-managed care says Normunds Daudiss, […]
Cardiolyse Frequently Asked Questions (FAQ)
When was Cardiolyse founded?
Cardiolyse was founded in 2015.
Where is Cardiolyse's headquarters?
Cardiolyse's headquarters is located at 2 Kuortaneenkatu, Helsinki.
What is Cardiolyse's latest funding round?
Cardiolyse's latest funding round is Biz Plan Competition.
Who are the investors of Cardiolyse?
Investors of Cardiolyse include Health Longevity Global Grand Challenge, Google for Startups Accelerator, Startupbootcamp Digital Health and Vertical Accelerator.
Who are Cardiolyse's competitors?
Competitors of Cardiolyse include Cardiomatics.
Compare Cardiolyse to Competitors
Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. Its AI-powered platform, Willem, delivers improvements to the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and prediction and the proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers for patient identification, risk stratification, and prognosis, as well as drug cardiac safety monitoring. The company was founded in 2018 and is based in Madrid, Spain.
Cardiolund provides software products for advanced ECG analysis. It offers software for automated ECG beats and rhythm analysis, as well as clinical research software for tracking the atrial fibrillatory frequency (AFR). It was founded in 2010 and is based in Lund, Sweden.
CardioAI is focused on providing deep learning technology to real-life products for natural language processing and healthcare. It offers productivity tools for clinical diagnosis, remote patient monitoring, and off-the-shelf software for digital health applications and devices. It was founded in 2015 and is based in Riga, Latvia.
Cardiomatics is a cloud AI tool for ECG analysis and is based in Poland.
CardioLogs provides a software technology enabling any healthcare professional to accurately and reliably screen patients for cardiovascular diseases. CardioLogs leverages machine learning technology and medical expertise to deliver top ECG interpretation services. On November 8th, 2021, Cardiologs was acquired by Philips. Terms of the transaction were not disclosed.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.